Pharmacoinformatic Screening of Natural Compounds to Identify Potential GPER1 Inhibitors

Extensive analyses have demonstrated that ZINC39470612 and ZINC72326045 are identified as potential compounds for targeting GPER1. These compounds also exhibited better binding affinities and ADME features than reported drugs and inhibitors. These in silico findings provide critical structural and functional insights with promising therapeutic relevance.